This review will discuss potential mechanisms by which CRP may play a direct role in mediating VTE pathogenesis, the clinical evidence for the role of CRP in predicting first episode VTE, recurrent VTE and in specific subsets of patients such as those with COVID-19 and cancer-associated thrombosis (CAT). Here, CRP is linked to deep vein thrombosis.